Skip to main content

Table 2 Grouping of the HCC patients

From: Identification of a five-immune gene model as an independent prognostic factor in hepatocellular carcinoma

Clinical Traits

Variable

Training Cohort

Testing Cohort

Entire Cohort

Survival status

Alive

106 (33.8%)

104 (30.3%)

220 (64.1%)

Dead

66 (16.4%)

67 (19.5%)

123 (35.9%)

  1. HCC hepatocellular carcinoma
Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us